Pericarp and seed of litchi and longan fruits: constituent, extraction, bioactive activity, and potential utilization.

Pericarp and seed of litchi and longan fruits: constituent, extraction, bioactive activity, and potential utilization. J Zhejiang Univ Sci B. 2019 Jun;20(6):503-512 Authors: Zhu XR, Wang H, Sun J, Yang B, Duan XW, Jiang YM Abstract Litchi (Litchi chinensis Sonn.) and longan (Dimocarpus longan Lour.) fruits have a succulent and white aril with a brown seed and are becoming popular worldwide. The two fruits have been used in traditional Chinese medicine as popular herbs in the treatment of neural pain, swelling, and cardiovascular disease. The pericarp and seed portions as the by-products of litchi and longan fruits are estimated to be approximately 30% of the dry weight of the whole fruit and are rich in bioactive constituents. In the recent years, many biological activities, such as tyrosinase inhibitory, antioxidant, anti-inflammatory, immunomodulatory, anti-glycated, and anti-cancer activities, as well as memory-increasing effects, have been reported for the litchi and longan pericarp and seed extracts, indicating a potentially significant contribution to human health. With the increasing production of litchi and longan fruits, enhanced utilization of the two fruit by-products for their inherent bioactive constituents in relation to pharmacological effects is urgently needed. This paper reviews the current advances in the extraction, processing, identification, and biological and pharmacological activities of constituents from litchi and longan by-prod...
Source: J Zhejiang Univ Sci ... - Category: Science Authors: Tags: J Zhejiang Univ Sci B Source Type: research

Related Links:

ConclusionAlthough clinicians should endeavor to offer alternative pain management strategies to all patients, those who are younger, are male patients, and report a history of or current substance use or mental health diagnoses were associated with a greater risk of developing opioid misuse. Clinicians should consider prioritizing alternative pain management strategies for these higher-risk patients.
Source: Annals of Emergency Medicine - Category: Emergency Medicine Source Type: research
Researchers from Uppsala University, Sweden, claim that for every one ovarian cancer case that is detected, five women are operated on, putting them at risk of pain, infection and blood loss.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Roughly one in three cancer survivors experiences chronic pain, and about one in six survivors have high impact pain that prevents them from performing everyday activities, according to new research published Thursday.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
THURSDAY, June 20, 2019 -- One-third of U.S. cancer survivors have chronic pain, and 1 in 6 have levels that restrict their daily activities, a new study finds. " The prevalence of chronic pain and high impact chronic pain among cancer survivors in...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
(American Cancer Society) A new report finds about one in three cancer survivors (34.6%) reported having chronic pain, representing nearly 5.4 million cancer survivors in the United States.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Incurable inflammatory breast cancer (IBC) patients occasionally suffer from general symptoms such as breast pain, bleeding, ulceration, and discharge, and thus require palliative radiotherapy (RT). Hypofracti...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
AbstractBackgroundAlthough the effectiveness of epidural anesthesia on pain control after esophagectomy has been reported, the appropriate insertion level of the epidural catheter remains unclear for adequate postoperative pain control. We investigated the relationship between the epidural catheter insertion level and postoperative pain control after esophagectomy for esophageal cancer.MethodsWe analyzed retrospectively 63 patients who underwent McKeown esophagectomy for esophageal cancer between October 2014 and November 2018. The epidural catheter was inserted at the T4 –T10 level before general anesthesia inductio...
Source: Esophagus - Category: Gastroenterology Source Type: research
Publication date: Available online 18 June 2019Source: Respiratory Medicine Case ReportsAuthor(s): Daisuke Shibahara, Makoto Furugen, Shiho Kasashima, Kozue Kaneku, Tomoko Yamashiro, Wakako Arakaki, Takuro Ariga, Eriko Atsumi, Hajime Aoyama, Hirofumi Matsumoto, Hiroki Maehara, Jiro FujitaAbstractA 70-year-old Japanese man with stage IV EGFR-mutated lung adenocarcinoma complained of right mild back pain. The patient had been heavily treated with several cytotoxic or molecular targeted agents for 10 years and received a palliative radiation therapy of 2nd sacral vertebra 5 years ago. Computed tomography showed the abnormal l...
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
ConclusionAll techniques achieved pain relief after 1 and 3  months, in up to 91% and 95% of patients respectively. MWA showed a negligible complication rate, whereas MRgFUS is associated with a noteworthy rate of adverse events. Future studies should adopt a standardized pain reporting scale to allow for meta-analysis.
Source: Skeletal Radiology - Category: Radiology Source Type: research
A Midwestern grocery chain, Hy-Vee, is taking an unusual—and highly controversial—approach to reducing health care costs. Before employees in certain cities can undergo knee replacement, they first must visit a stem cell provider. Hy-Vee has contracted with one of the U.S.’ leading stem cell companies—Regenexx, based in Des Moines, Iowa—that claims injections of concentrated bone marrow or platelets can help patients avoid expensive joint surgery. Regenexx has persuaded over 100 employers to include its services in their health insurance plans. In a marketing booklet, Regenexx, whose injection...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Healthcare medicine Source Type: news
More News: Antidoxidants | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | China Health | Fruit | Heart | Herbs | Pain | Science